| Dr Srikrishna Mylavarapu, MD | |
|
5900 S Lake Dr, Cudahy, WI 53110-3171 | |
| (414) 489-4125 | |
| (414) 489-4056 |
| Full Name | Dr Srikrishna Mylavarapu |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 33 Years |
| Location | 5900 S Lake Dr, Cudahy, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700993136 | NPI | - | NPPES |
| 33349600 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 40767 (Minnesota) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 44856 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Allis Memorial Hospital | West allis, WI | Hospital |
| Aurora St Lukes Medical Center | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
A new study co-led by Hsin-Hsiung Tai, professor of pharmaceutical sciences at the University of Kentucky, suggests that a key prostaglandin (PG) metabolic enzyme shows promise as a drug target to help tissue regeneration and repair, particularly after bone marrow transplantation and tissue injuries.
Researchers at the University of Rochester have developed a novel optical technique that permits rapid analysis of single human immune cells using only light.
ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the introduction of its Dip and Read Ni-NTA biosensor for use on its Octet and BLItz instrumentation platforms.
The Pulmonary Hypertension Association (PHA), in conjunction with leading pulmonary hypertension specialists, has announced the launch of an educational campaign to raise awareness of the association between pulmonary arterial hypertension (PAH) and stimulant use, particularly methamphetamine use.
Australian scientists, in association with US pharmaceutical company DiaKine Therapeutics, have shown that a drug candidate, Lisofylline, could be useful in treating Type 2 diabetes.
› Verified 6 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
A new study co-led by Hsin-Hsiung Tai, professor of pharmaceutical sciences at the University of Kentucky, suggests that a key prostaglandin (PG) metabolic enzyme shows promise as a drug target to help tissue regeneration and repair, particularly after bone marrow transplantation and tissue injuries.
Researchers at the University of Rochester have developed a novel optical technique that permits rapid analysis of single human immune cells using only light.
ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the introduction of its Dip and Read Ni-NTA biosensor for use on its Octet and BLItz instrumentation platforms.
The Pulmonary Hypertension Association (PHA), in conjunction with leading pulmonary hypertension specialists, has announced the launch of an educational campaign to raise awareness of the association between pulmonary arterial hypertension (PAH) and stimulant use, particularly methamphetamine use.
Australian scientists, in association with US pharmaceutical company DiaKine Therapeutics, have shown that a drug candidate, Lisofylline, could be useful in treating Type 2 diabetes.
› Verified 6 days ago
| Entity Name | Mental Health Emergency Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255099941 PECOS PAC ID: 3274916044 Enrollment ID: O20220922000219 |
News Archive
A new study co-led by Hsin-Hsiung Tai, professor of pharmaceutical sciences at the University of Kentucky, suggests that a key prostaglandin (PG) metabolic enzyme shows promise as a drug target to help tissue regeneration and repair, particularly after bone marrow transplantation and tissue injuries.
Researchers at the University of Rochester have developed a novel optical technique that permits rapid analysis of single human immune cells using only light.
ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the introduction of its Dip and Read Ni-NTA biosensor for use on its Octet and BLItz instrumentation platforms.
The Pulmonary Hypertension Association (PHA), in conjunction with leading pulmonary hypertension specialists, has announced the launch of an educational campaign to raise awareness of the association between pulmonary arterial hypertension (PAH) and stimulant use, particularly methamphetamine use.
Australian scientists, in association with US pharmaceutical company DiaKine Therapeutics, have shown that a drug candidate, Lisofylline, could be useful in treating Type 2 diabetes.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Srikrishna Mylavarapu, MD 3301 W Forest Home Ave, Milwaukee, WI 53215-2843 Ph: (414) 647-6326 | Dr Srikrishna Mylavarapu, MD 5900 S Lake Dr, Cudahy, WI 53110-3171 Ph: (414) 489-4125 |
News Archive
A new study co-led by Hsin-Hsiung Tai, professor of pharmaceutical sciences at the University of Kentucky, suggests that a key prostaglandin (PG) metabolic enzyme shows promise as a drug target to help tissue regeneration and repair, particularly after bone marrow transplantation and tissue injuries.
Researchers at the University of Rochester have developed a novel optical technique that permits rapid analysis of single human immune cells using only light.
ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the introduction of its Dip and Read Ni-NTA biosensor for use on its Octet and BLItz instrumentation platforms.
The Pulmonary Hypertension Association (PHA), in conjunction with leading pulmonary hypertension specialists, has announced the launch of an educational campaign to raise awareness of the association between pulmonary arterial hypertension (PAH) and stimulant use, particularly methamphetamine use.
Australian scientists, in association with US pharmaceutical company DiaKine Therapeutics, have shown that a drug candidate, Lisofylline, could be useful in treating Type 2 diabetes.
› Verified 6 days ago
Dr. Noel K Garchitorena, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 5900 S Lake Dr, Cudahy, WI 53110 Phone: 414-489-9000 | |
Maximo L Cueto, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5900 S Lake Dr, Cudahy, WI 53110 Phone: 414-489-4125 Fax: 414-489-4056 | |
Shaik O Sayeed, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5900 S. Lake Dr., Lakeshore Medical Clinic, Cudahy, WI 53110 Phone: 414-489-4190 Fax: 414-489-4015 |